Intrinsic Value

The intrinsic value of Certara Inc (CERT) under the Base Case is 10.39 USD per share. Compared with the current market price of 10.55 USD, the stock appears Overvalued by 1% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

CERT Intrinsic Value
$10.39
Overvaluation 1%
Intrinsic Value
Price $10.55

CERT is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alert me when CERT is below its intrinsic value
Today $8.31 · 21.2% below the current price
Alternatives to CERT

Fundamental Analysis

What Certara Does

Health Care

Certara helps drug makers use software and scientific consulting to design and test medicines before and during clinical development. Its main products are biosimulation software tools, data and modeling platforms, and expert services that help customers predict how a drug will behave in the body and choose better trial designs.

Headquarters
United States of America US
Employees
1 515
IPO date
Dec 11, 2020
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 5, 2026

Certara reported strengthening software momentum and progress on operating changes while continuing a broad commercial and product overhaul.

Open the earnings call
EPS
$0.06
Expected
$0.05
Surprise
+20.0%
Stock, day of the call
+9.8%
View Earnings Call

Past 12 months

Continue CERT Research

Decided on Certara? Get an email when CERT reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one CERT stock?

The intrinsic value for Certara Inc (CERT) under the Base Case is 10.39 USD.

Is CERT stock undervalued or overvalued?

Compared with the current market price of 10.55 USD, the stock appears Overvalued by 1% .

How reliable are our estimates? See how past valuations played out
Back to Top